As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

A University of Minnesota-led review is urging federal health advisers to maintain a longstanding immunization strategy that ...

Ahead of vaccine advisory meeting, evidence review finds hepatitis B vaccine "remarkably s ...

The review was carried out and released by the Vaccine Integrity Project, which is dedicated to bolstering vaccines in the U.S.

The CDC’s vaccine advisors, led by a newly named chair, will discuss making more changes to the childhood vaccine schedule ...

The Centers for Disease Control and Prevention (CDC) first recommended vaccinating all babies against hepatitis B at birth in ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

Signs Master Services Agreement With Only Orphans Cote For NV-387 Orphan Drug Strategy. NanoViricides, Inc. (NYSE American: NNVC), a clinical stage global pioneer in broad-spectrum antivirals based on ...

Bristol Myers Squibb BMY and Gilead Sciences, Inc. GILD are leading biotechnology companies with broad, diverse portfolios and a global footprint. BMY boasts a strong portfolio with drugs for oncology ...

Learn more about whether Immunocore Holdings plc or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ ...

The risk of HIV transmission through blood transfusion in India has dipped over the years due to improved screening and ...